A committee of outside clinical trial observers has recommended that Praxis Precision Medicines stop testing its experimental treatment for essential tremor after an interim analysis of one study ...
Encora Therapeutics today announced that Encora X1™, its FDA-cleared wearable for adults with essential tremor, is now ...
Encora Therapeutics developed an FDA-cleared wearable treatment for essential tremor from a prototype originally created by MIT students as part of the university's 2.009 Product Engineering Processes ...
Praxis Precision Medicines plans to start a phase 3 trial of ulixacaltamide in essential tremor in the second half of the year. (asbe/iStock/Getty Images Plus) Praxis Precision Medicines isn’t letting ...
Essential tremor affects millions, making even simple tasks like eating or writing a challenge. While medications can help, they do not work for everyone. Neurosurgeon Shervin Rahimpour, MD, explains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results